Description
Legal Disclaimer
This information has not been reviewed or endorsed by the US FDA. It is provided solely for educational and research purposes. Tirzepatide is not approved for medical use, human consumption, or as a therapeutic treatment.
Product Details
- Quantity: 10mg per vial
- Purity: ≥99%, Rigorous third-party testing
- Packaging: Secure, sealed, and tamper-proof vials
- Source: Synthesized using advanced peptide synthesis techniques
- Note: This product is sold in lyophilized powder form and must be reconstituted before use.
Overview
A revolutionary tool in metabolic and obesity research, Tirzepatide is a dual-receptor agonist that targets both GLP-1 and GIP receptors. This combination enhances the peptide’s effectiveness in regulating appetite, managing blood glucose levels, and improving insulin sensitivity. With its unique dual mechanism of action, Tirzepatide provides a more advanced model for researchers investigating weight loss, hormonal balance, and type 2 diabetes.
Research Specifics
- Metabolic Research: Studied for its ability to enhance insulin sensitivity and promote energy efficiency.
- Obesity Studies: Shown to support significant bodyweight reduction and improved fat-to-lean mass ratio.
- Diabetes Research: Actively explored for its glucose-lowering effects and support in managing insulin resistance.
- Hormonal Regulation: Offers insight into the interaction of incretin pathways and their role in appetite and metabolic health.
Technical Specifications
- Molecular Formula: C225H348N48O68
- Purity: ≥99% (HPLC-verified)
- Form: Lyophilized powder
- Storage: Store at -20°C for long-term stability
- Solubility: Requires reconstitution with sterile bacteriostatic water or a suitable solvent before use
Reviews
There are no reviews yet.